Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction (FRAMITO)
Sponsor: University Hospital of Ferrara
Listed as NCT06433427, this observational or N/A phase trial focuses on Aging and Chronic Disease and remains ongoing. Sponsored by University Hospital of Ferrara, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
May 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital of Ferrara
- University of Milano Bicocca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.